Thomson StreetEvents

Title:Encysive Pharmaceuticals Inc. at JPMorgan 25th Annual Healthcare Conference Transcript
Price:$54.00
Publication Date:Jan 11, 2007
Source:Thomson StreetEvents
Report Type:Transcript
Abstract:Final Transcript of ENCY presentation, 11-Jan-07 10:30am PT
Brief Excerpt:... - JPMorgan - Biotechnology Analyst Good morning. Welcome to the last day of the JPMorgan Healthcare conference. I'm Geoff Meacham, Biotechnology Analyst here at JPMorgan. It is my pleasure to introduce Encysive Pharmaceuticals, one of the leading companies in the pulmonary hypertension space anchored by THELIN, which is approved in Europe and awaiting approval at the FDA. Also, TBC####, a drug in clinical development for resistant hypertension, rounds out the pipeline there. And speaking on behalf of Encysive is CEO Dr. Bruce Given. ...
Word Count:4555
Length:7 Pages
Ticker:ENCY
Time:10:30am PT
Related Report(s):
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $54.00

Thomson StreetEvents

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

  about us contact us public company index private company index pcan your privacy rights terms & conditions